<DOC>
	<DOC>NCT01282294</DOC>
	<brief_summary>This post market clinical follow-up is to confirm the clinical usefulness of the Expert Tibial Nail (ETN) PROtect device for operative stabilization in patients with a tibia fracture as measured by the quality of life (EQ5D, SF-12) instruments, disease-specific questionnaires (Iowa Ankle Score, WOMAC) and assessment of (Non-)Device Related Adverse Events or complications.</brief_summary>
	<brief_title>Clinical Follow-up to Evaluate the Clinical Usefulness of Gentamicin-coated Titanium Nails in Tibia Fractures</brief_title>
	<detailed_description />
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Tibial Fractures</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<criteria>Adult patients aged 18 years or more Open or closed tibia fracture according to the surgical technique Women who are pregnant or breastfeeding or are planning to become pregnant during the study Patients with consumptive/ malignant primary disease and a life expectancy of &lt; 3 months Patients with a known allergy to aminoglycosides Physical or mental incapacity, which makes it impossible to obtain informed consent History of drug and alcohol abuse Patient unlikely to cooperate Legal incompetence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>